Immunotherapy drug offers hope to head and neck cancer patients

Some patients responded extremely well to pembrolizumab, with a minority still cancer free three years after first receiving the drug. . https://www.heraldscotland.com/news/17269343.immunotherapy-drug-offers-hope-to-head-and-neck-cancer-patients/